CERO THERAPEUTICS HOLDINGS, INC. Basic Shares Outstanding (Weighted Average)
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Basic Shares Outstanding (Weighted Average) of 42.18 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 42.18M shares, a 8541.08% increase year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 28.76M shares, a 16678.45% increase year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.26M shares, a 4992.54% increase year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 488.08K shares, a 5926.37% increase year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 5.84K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 1 month | Weighted Average Number of Shares Outstanding, Basic 1 month as first filed | Weighted Average Number of Shares Outstanding, Basic 2 month | Weighted Average Number of Shares Outstanding, Basic 2 month as first filed | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 5 month | Weighted Average Number of Shares Outstanding, Basic 5 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 8 month | Weighted Average Number of Shares Outstanding, Basic 8 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 11 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 42.18M shares 10-Q · filed 2026-08-14 | 38.57M shares 10-Q · filed 2026-08-14 | ||||||||||||
| 2026-03-31 | 28.76M shares 10-Q · filed 2026-05-15 | |||||||||||||
| 2025-09-30 | 1.26M shares 10-Q · filed 2025-11-19 | 876.48K shares derived: average of 2 quarters · filed 2026-08-14 | 645.45K shares 10-Q · filed 2025-11-19 | |||||||||||
| 2025-06-30 | 488.08K shares 10-Q · filed 2026-08-14 | 330.60K shares 10-Q · filed 2026-08-14 | ||||||||||||
| 2025-03-31 | 171.38K shares 10-Q · filed 2026-05-15 | 3.43M shares 10-Q · filed 2025-05-15 | ||||||||||||
| 2024-12-31 | 579.43K shares 10-K · filed 2025-04-15 | |||||||||||||
| 2024-09-30 | 24.84K shares 10-Q · filed 2025-11-19 | 49.68M shares 10-Q/A · filed 2024-11-20 | 16.47K shares derived: average of 2 quarters · filed 2025-11-19 | 15.00K shares 10-Q · filed 2025-11-19 | 30.00M shares 10-Q/A · filed 2024-11-20 | |||||||||
| 2024-06-30 | 8.10K shares 10-Q · filed 2025-08-22 | 16.20M shares 10-Q · filed 2024-08-14 | 7.86K shares 10-Q · filed 2025-08-22 | 15.72M shares 10-Q · filed 2024-08-14 | ||||||||||
| 2024-03-31 | 141.13K shares 10-Q · filed 2025-05-15 | 14.11M shares 10-Q · filed 2024-05-17 | ||||||||||||
| 2024-02-13 | 292.00 shares 10-Q · filed 2025-11-19 | 9.07M shares 10-Q · filed 2024-05-17 | ||||||||||||
| 2023-12-31 | -27.15M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-04-15 | -9.04M shares derived: average of 2 quarters · filed 2025-04-15 | -3.01M shares derived: average of 3 quarters · filed 2025-04-15 | 5.84K shares 10-K · filed 2025-04-15 | ||||||||||
| 2023-09-30 | 9.07M shares 10-Q/A · filed 2024-11-20 | 9.07M shares derived: average of 2 quarters · filed 2024-11-20 | 9.06M shares 10-Q/A · filed 2024-11-20 | |||||||||||
| 2023-06-30 | 9.06M shares 10-Q · filed 2024-08-14 | 9.06M shares 10-Q · filed 2024-08-14 | ||||||||||||
| 2023-03-31 | 9.06M shares 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |